Forbes‘ columnist recently picked up work created by ATI Advisory supporting the value of offering beneficiaries supplemental benefits.
With MA Cuts Coming, Home Care Supplemental Benefits Hang In The Balance
Anne Tumlinson foresees a benefit-offering slowdown in Medicare Advantage with a caveat in a discussion with Home Health Care News,Read More Read More
As US Begins to Tackle High Drug Prices, Congress Gets in the Way
Anna Kaltenboeck writes in Bloomberg Law that Protecting Health Care for All Patients Act legislation would complicate efforts to lower drug prices in the U.S. and undermine Medicare’s new negotiating authority if the bill becomes law.Read More Read More
Drugmaker Data, Price Negotiation Timeline Tee Up Fight With HHS
Anna Kaltenboeck discusses how the Centers for Medicare and Medicaid Services is preparing for prescription drug pricing negotiation with manufacturers with the Inflation Reduction Act now in place.Read More Read More